auto_awesome_motion View all 1 versions
organization

TTOP

TTOPSTART BV
Country: Netherlands
11 Projects, page 1 of 3
  • Open Access mandate for Publications
    Funder: EC Project Code: 731623
    Overall Budget: 6,000,000 EURFunder Contribution: 6,000,000 EUR
    Partners: KUL, TTOP, GRANZER REGULATORY CONSULTING & SERVICES, ECPC, ISA, INC RESEARCH UK LTD

    Cervical cancer (CxCa) is caused by high risk types of the human papillomavirus (a.o. HPV16). Prophylactic HPV vaccination is not the standard of care in all European countries, and where approved it is not sufficiently adopted. Once infected, these vaccines no longer p...

  • Open Access mandate for Publications
    Funder: EC Project Code: 634893
    Overall Budget: 5,834,340 EURFunder Contribution: 5,834,340 EUR
    Partners: UCL, UCLH, NORDIC BIOSCIENCE CLINICAL DEVELOPMENT, University of Tübingen, TTOP, UoA, Eli Lilly and Company Limited, AUDION, LINICAL NETHERLANDS B.V.

    Hearing loss is a chronic non-communicable disease disabling over 328 million adults, and 32 million children worldwide. Sensorineural hearing loss due to loss of auditory hair cells was long thought to be irreversible. However, recent animal studies have demonstrated t...

  • Open Access mandate for Publications
    Funder: EC Project Code: 733266
    Overall Budget: 1,999,620 EURFunder Contribution: 1,999,620 EUR
    Partners: ASTP, TTOP, EP, KI, VIS, Innovation Engineering (Italy), Senvion SE (Germany), EU, PNO ADVIESGROEP, TTS...

    A recent evaluation of FP7 projects executed by the EC, showed that an estimated 80% of funded Health projects lacks valorisation. The “UTILE” proposal presents the EU-Health Innovation Marketplace, an online tool to better valorise the FP7 Health and Horizon2020 SC1 pr...

  • Open Access mandate for Publications and Research data
    Funder: EC Project Code: 874807
    Overall Budget: 9,526,100 EURFunder Contribution: 9,526,100 EUR
    Partners: UCL, Medical University of Graz, Universitätsklinikum Erlangen, Centre Hospitalier Universitaire de Rouen, AU, AUH, QMUL, NHSBT, IIS-FJD, CVBF...

    Faecal incontinence (FI) is a common condition affecting ~67 million people in Europe, seriously impairing living and productivity of affected individuals and their families. Women with FI arising from childbirth injury may benefit from regenerative medicine using autol...

  • Open Access mandate for Publications
    Funder: EC Project Code: 686089
    Overall Budget: 8,291,220 EURFunder Contribution: 8,291,220 EUR
    Partners: RADBOUDUMC, IOX, INT, University of Konstanz, UOXF, SPECIALIZED MEDICAL SERVICES-ONCOLOGY BV, ITEOS, EVONIK CREAVIS GMBH, MOLECURE SPOLKA AKCYJNA, TTOP...

    PRECIOUS aims at scaling-up biodegradable nanomedicines for multimodal precision cancer immunotherapy. With 3.5 million cancer patients in Europe every year, new cancer medicines are eagerly awaited, notably for prostate and ovarian cancer. Systemically applied new immu...